Stem Cell Banking Market is Estimated to Witness Significant Growth Owing to Increasing Support for Regenerative Medicine
![]() |
Stem Cell Banking Market |
Stem cell banking refers to the
process of collecting, preserving, and storing stem cells obtained from body
tissues (umbilical cord blood and tissues, placenta, and amniotic fluid) for
potential future use in stem cell therapies. Stem cells are cells found in all
humans and animals with the remarkable potential to develop into many different
types of cells in the body. Stem cells can theoretically divide without limit
to replenish other cells as long as the person or animal is still alive. When a
stem cell divides, each new cell has the potential either to remain a stem cell
or become another type of cell with a more specialized function, such as a
muscle cell, a red blood cell, or a brain cell.
The global stem cell banking
market is estimated to be valued at US$
534.81 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising prevalence of chronic
conditions is anticipated to drive growth of the stem cell banking market over
the forecast period. According to the Centers for Disease Control and
Prevention, in the United States chronic diseases such as heart disease, cancer,
and diabetes are the leading causes of death and disability in America.
Additionally, according to the World Health Organization's (WHO) statistics,
the burden of chronic diseases is rapidly increasing both in developed and
developing nations posing challenges for health systems globally. For instance,
cancer is projected to surpass heart disease as the leading cause of death
globally by 2030. Therefore, the increasing prevalence of chronic diseases is
expected to generate increased demand for stem cell-based therapies, thereby
boosting market growth.
Furthermore, increasing awareness
about the therapeutic potential of stem cells is also expected to propel growth
of the stem cell banking market during the forecast period. Stem cell research
is evolving at a rapid pace paving way for new therapeutic discoveries and
applications. Active involvement of various government and non-government
organizations in spreading awareness about the benefits of stem cell therapy
and stem cell banking is fueling adoption.For Instance, initiatives by
International Society for Stem Cell Research (ISSCR) to spread awareness about
stem cell science and its clinical applications is supporting overall market
expansion.
SWOT Analysis
Strength: The stem cell banking
market has high growth potential. With increase in genetic disorders and
chronic diseases, demand for stem cell banking will increase. Stem cell banking
offers new treatment options for otherwise incurable diseases. Government
initiatives to promote stem cell research will further boost the market.
Weakness: High costs associated
with stem cell collection, processing, cryopreservation and storage limits the
adoption of stem cell banking services. Lack of awareness about stem cell
therapy among public also hampers market growth.
Opportunity: Increasing R&D
activities to develop new therapeutic applications of stem cells will create
new market opportunities. Collaboration between private players and research
institutes can increase commercialization of stem cell therapies. Emerging
economies offer scope to expand due to growing healthcare investments and
patient pool.
Threats: Ethical issues related
to embryonic stem cell research and legal regulations on the same vary across
regions posing challenges. Limited donor base for stem cell collection and low
success rates of stem cell transplant therapies also threaten market prospects
to some extent.
Key Takeaways
The Global
Stem Cell Banking Market Size is expected to witness high growth.
Regional analysis related content comprises growing at a CAGR of 5.4% during the forecast period. North America currently
dominates the market due to favorable governmental initiatives and presence of
strong healthcare infrastructure. Asia Pacific stem cell banking market is
expected to witness fastest growth over the next few years with India and China
emerging as lucrative investment destinations in the domain.
Key players operating in the stem cell banking market are CM Fine
Chemica, Cayman Chemical, Santa Cruz Biotechnology, Stemcell Technologies,
Bio-Techne, Merck Millipore, Thermo Fisher Scientific and Lonza. Collaborations
between private stem cell banks and research institutes are expected to
expedite commercialization of new therapies. Growing public-private
partnerships in developing economies will expand regional market potential.
Ethical and legal issues pose threats and require coordinated efforts from
stakeholders to realize full prospects.
Get More Insights Here
https://www.newswirestats.com/stem-cell-banking-market-analysis-size-share-growth-outlook-2023/
Comments
Post a Comment